NHI reimbursement approved for GSK's Relenza for bird flu.
Relenza is a Neuramidase inhibiting anti-viral drug like Tamiflu, Roche's bird flu therapy and the MOHW seemed to approve it because an alternative ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
